This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $7,980.49 firm fixed price delivery order is for the pharmaceutical product Ganirelix Acetate 250 mcg/0.5 mL, with a completion date of July 5, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for AmerisourceBergen to deliver a broad range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract award does not have a set-aside designation.
Generated 10/2/24, 10:03 AM